Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ansseau

Showing results (221-230 of 267) with videos related to

Pageof 27
Sort By:
Plos One|November 5, 2011
The FSHD atrophic myotube phenotype is caused by DUX4 expressionCéline Vanderplanck, Eugénie Ansseau, Sébastien Charron, et al.
Psychiatry Research|November 1, 1987
Neuroendocrine evaluation of catecholaminergic neurotransmission in maniaM Ansseau, R von Frenckell, J L Cerfontaine, et al.
Journal of Analytical Toxicology|February 5, 2015
Estimation of the Time Interval between the Administration of Heroin and the Sampling of Blood in Chronic InhalersNathalie Dubois, Claude Hallet, Laurence Seidel, et al.
Analytical and Bioanalytical Chemistry|November 17, 2018
Correction to: Affinity capillary electrophoresis for identification of active drug candidates in myotonic dystrophy type 1Ioan O Neaga, Stephanie Hambye, Ede Bodoki, et al.
Acta Psychiatrica Belgica|September 1, 1985
[Novel comparative profile of the clinical activity of antidepressive agents]M Ansseau, S Diricq, M Bataille, et al.
Acta Psychiatrica Belgica|March 1, 1988
[Assessment of the clinical activity of fluoxetin (Prozac) according of the "Stars of Liège" model]M Ansseau, M Bataille, D Bobon, et al.
Drug and Alcohol Dependence|January 17, 2004
Personality profile and drug of choice; a multivariate analysis using Cloninger's TCI on heroin addicts, alcoholics, and a random population groupO Le Bon, P Basiaux, E Streel, et al.
Journal of Affective Disorders|March 4, 2000
Efficacy and safety of tianeptine in the treatment of depressive disorders in comparison with fluoxetineH Lôo, J Saiz-Ruiz, Costa e Silva JACE, et al.
Pharmacopsychiatry|October 1, 1995
The flesinoxan 5-HT1A receptor challenge in major depression and suicidal behaviorW Pitchot, M Ansseau, A Gonzalez Moreno, et al.
Journal of Affective Disorders|December 1, 1984
Double-blind clinical study comparing alprazolam and doxepin in primary unipolar depressionM Ansseau, C Ansoms, G Beckers, et al.
Pageof 27

Showing results (221-230 of 267) with videos related to

Sort By:
Pageof 27
Plos One|November 5, 2011
The FSHD atrophic myotube phenotype is caused by DUX4 expressionCéline Vanderplanck, Eugénie Ansseau, Sébastien Charron, et al.
Psychiatry Research|November 1, 1987
Neuroendocrine evaluation of catecholaminergic neurotransmission in maniaM Ansseau, R von Frenckell, J L Cerfontaine, et al.
Journal of Analytical Toxicology|February 5, 2015
Estimation of the Time Interval between the Administration of Heroin and the Sampling of Blood in Chronic InhalersNathalie Dubois, Claude Hallet, Laurence Seidel, et al.
Analytical and Bioanalytical Chemistry|November 17, 2018
Correction to: Affinity capillary electrophoresis for identification of active drug candidates in myotonic dystrophy type 1Ioan O Neaga, Stephanie Hambye, Ede Bodoki, et al.
Acta Psychiatrica Belgica|September 1, 1985
[Novel comparative profile of the clinical activity of antidepressive agents]M Ansseau, S Diricq, M Bataille, et al.
Acta Psychiatrica Belgica|March 1, 1988
[Assessment of the clinical activity of fluoxetin (Prozac) according of the "Stars of Liège" model]M Ansseau, M Bataille, D Bobon, et al.
Drug and Alcohol Dependence|January 17, 2004
Personality profile and drug of choice; a multivariate analysis using Cloninger's TCI on heroin addicts, alcoholics, and a random population groupO Le Bon, P Basiaux, E Streel, et al.
Journal of Affective Disorders|March 4, 2000
Efficacy and safety of tianeptine in the treatment of depressive disorders in comparison with fluoxetineH Lôo, J Saiz-Ruiz, Costa e Silva JACE, et al.
Pharmacopsychiatry|October 1, 1995
The flesinoxan 5-HT1A receptor challenge in major depression and suicidal behaviorW Pitchot, M Ansseau, A Gonzalez Moreno, et al.
Journal of Affective Disorders|December 1, 1984
Double-blind clinical study comparing alprazolam and doxepin in primary unipolar depressionM Ansseau, C Ansoms, G Beckers, et al.
Pageof 27